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Morphine Pharmacodynamics in Mechanically Ventilated
Preterm Neonates Undergoing Endotracheal Suctioning
PA V€alitalo1, EHJ Krekels1, M van Dijk2,3, SHP Simons3, D Tibboel2 and CAJ Knibbe1,2,4*
To date, morphine pharmacokinetics (PKs) are well quantified in neonates, but results about its efficacy are ambiguous. This
work presents an analysis of a previously published study on pain measurements in mechanically ventilated preterm
neonates who received either morphine or placebo to improve comfort during invasive ventilation. The research question was
whether morphine reduces the pain associated with endotracheal or nasal suctioning before, during, and after suctioning.
Because these neonates cannot verbalize their pain levels, pain was assessed on the basis of several validated pain
measurement instruments (i.e., COMFORT-B, preterm infant pain profile [PIPP], Neonatal Infant Pain Scale (NIPS), and visual
analogue scale (VAS)). The item response theory (IRT) was used to analyze the data in order for us to handle the data from
multiple-item pain scores. The analysis showed an intra-individual relationship between morphine concentrations and pain
reduction, as measured by COMFORT-B and VAS. However, the small magnitude of the morphine effect was not considered
clinically relevant for this intervention in preterm neonates.
CPT Pharmacometrics Syst. Pharmacol. (2017) 6, 239–248; doi:10.1002/psp4.12156; published online 21 January 2017.
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE
TOPIC?
 Morphine PKs in neonates are well characterized,
and PD studies so far have shown ambiguous efficacy
for pain caused by invasive ventilation. However, the
lack of efficacy could be an artefact due to difficulty in
assessing pain in neonates.
WHAT QUESTION DID THIS STUDY ADDRESS?
 Is morphine effective in treating pain related to inva-
sive ventilation and endotracheal suctioning in preterm
neonates?
WHAT THIS STUDY ADDS TO OUR KNOWLEDGE
 This model-based analysis captures data from differ-
ent pain scales into a single latent variable, pain, using
IRT, thereby increasing the signal/noise ratio. The same
approach can be used as a framework for future analy-
ses of pain and distress studies. The analgesic effect
of morphine in mechanically ventilated neonates is
quantified.
HOW MIGHT THIS CHANGE DRUG DISCOVERY,
DEVELOPMENT, AND/OR THERAPEUTICS?
 The analysis shows how the observational clinical
pain scales in neonates can be better utilized so that
they are more informative about the clinically relevant
endpoint, thereby allowing for a more detailed charac-
terization of the drug concentration-effect relationship.
Morphine is used in hospitalized neonates for the treatment
of moderate to severe pain, however, results on the efficacy
of morphine to improve comfort during invasive ventilation
in this population are ambiguous.1–3 A between-group
statistical analysis of data from two large, double-blind, pla-
cebo-controlled studies in the early 2000s suggested that
morphine has no advantage over placebo in one study,1
whereas the other suggested an analgesic effect at some
but not all time points.2 However, a subsequent population
analysis of the concentration-effect relationship using the
same data2 led the authors of the latter study to conclude
that morphine has no analgesic effect.3
The gold standard for pain assessment in adults is self-
report, but preverbal children cannot express their pain this
way. Therefore, dedicated pain scales have been developed
and validated for assessment of pain in preterm neonates.
In total, over 40 different pain assessment tools exist for
quantifying pain in neonates.4–6
We hypothesized that the observed lack of morphine
efficacy could be due to pain being difficult to quantify in
neonates. We recently published a study about the informa-
tiveness of items from two neonatal pain scales, the COM-
FORT scale7 and the preterm infant pain profile (PIPP)
score,8 using item response theory (IRT) modeling.9 A high
variability was found in the ability of the items of both pain
scales to discriminate between pain levels. This may have
obscured the results of the original studies, which used
total COMFORT and PIPP scores to assess pain on mor-
phine efficacy.1,2 A more powerful approach would be to
consider item-level data, possibly from multiple pain scores,
to derive a single latent variable using IRT modeling, and
then examine the drug effects on the derived latent
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variable. This way, items are not assumed to be equally
sensitive in detecting pain. IRT has been proposed for
pharmacodynamic (PD) studies as an attractive statistical
method to derive a latent variable from ordered categorical
data.10
The aim of the current study was to assess the morphine
concentration-effect relationship in mechanically ventilated
neonates, using a previously developed population pharma-
cokinetic (PK) model11 to predict morphine concentrations
and IRT based on multiple neonatal pain scores to quantify
pain.
METHODS
Study design
The details of the study are reported in the original publica-
tion1 and are briefly repeated here.
The data were obtained from 140 preterm neonates
undergoing mechanical ventilation in a randomized double-
blind, double-dummy trial comparing morphine (n5 71) vs.
placebo (n569) in treatment of pain related to invasive
ventilation and endotracheal suctioning. The neonates
received a loading dose of either morphine (100 mcg/kg) or
saline followed by a continuous infusion of either morphine
(10 mcg/kg) or saline. Both groups were allowed open-label
rescue morphine of 50 mcg/kg bolus dose followed by 5–
10 mcg/kg/h infusion, if needed. Some neonates in the pla-
cebo group had received an earlier loading dose of mor-
phine at the start of mechanical ventilation, prior to the
start of the current study. Sparse samples for concentra-
tions of morphine and morphine glucuronides was available
for each patient. In total, 25 patients in the placebo group
received no morphine at all. Ten patients of the original tri-
al1 were not included in the current study because they
were extubated early, or there were other reasons to termi-
nate the study early. The local ethics committees of the
study centers had approved the original study protocol.
The mean bodyweight of the included patients was
1400 g (SD5 725 g) and mean postmenstrual age was 211
days (SD524.4 days). Twenty-nine neonates were “small
for gestational age” (i.e., birthweight in the lowest 2.5 per-
centile for that gestational age; this definition differs from
the World Health Organization definition, which uses the
lowest 10th percentile). One hundred thirty-three of the
patients were recruited at a postnatal age of 1 day, and the
remaining seven at postnatal age of 2 or 3 days.
Pain was assessed at baseline, before administration of
study medication, 30 minutes after the loading dose, and
twice daily at standardized time points around endotracheal
suctioning. The time points of endotracheal suctioning were
not standardized. For each assessment, pain was recorded
before, during, and after suctioning. Suctioning was per-
formed more frequently (range, 0–24 procedures per day)
than the pain assessments. Pain was quantified using
COMFORT,7 PIPP scores,8 and visual analogue scale
(VAS) scores,12 assessed by two investigators based on
video recordings.
COMFORT is an eight-item pain assessment tool, with
six behavioral items (alertness, calmness/agitation, respira-
tory response, body movement, muscle tension, and facial
tension) and two physiological items (heart rate and blood
pressure), each graded between one and five. PIPP is a
seven-item pain assessment scale, with three behavioral
items (brow bulge, eye squeeze, and nasolabial furrow)
graded between zero and three and four remaining items
(gestational age, behavior before painful stimulus, heart
rate, and oxygen saturation). For COMFORT and PIPP
scores, individual item-level data were available, although
the COMFORT item “muscle tension” could not be
assessed based on the video recordings. Only behavioral
items of these scores were included in the analysis
because physiological items have been shown previously to
be uninformative of pain in mechanically ventilated preterm
infants.9 Furthermore, nurse-assessed VAS scores and
composite scores for the Neonatal Infant Pain Scale
(NIPS)13 (range, 0–7) obtained at the time of the study,
were used in the analysis. A total of 16,257 item-level
COMFORT, PIPP, NIPS, and VAS recordings were included
in the current analysis. Mean scores of the data, along with
numbers of observations, are summarized in Table 1.
Modeling procedures
All modeling procedures were conducted with NONMEM
7.3,14 using the Laplace method, with GFortran version
4.8.4 and Perl-speaks-NONMEM version 4.4.0 for run con-
trol.15 Data management and graphical visualization was
performed using the R statistical software, version 3.1.1.16
The modeling was performed sequentially, as summa-
rized in Figure 1. First, an IRT model was fitted to the
available pain data, which is detailed in the subsection
“graded response model for pain.” Subsequently, the
parameters of the graded response model were fixed to the
final estimates to reduce runtimes.
Second, as detailed in the subsection “pharmacodynamic
modeling,” morphine and morphine glucuronide concentra-
tions were tested as predictors of pain. A previously estab-
lished population PK model was used to predict the
morphine and morphine glucuronide concentrations at the
Table 1 Mean pain scores of individual items before, during, and after suctioning
Suction status
COMFORT
(1–5; video)
NIPS
(0–7; nurse)
PIPP
(0–3; video)
VAS
(0–10; nurse)
VAS
(0–10; video)
Before 2 (0.76; 3,100) 0.77 (1.4; 622) 1.1 (1.2; 715) 0.91 (0.93; 619)
During 3 (0.83; 3,147) 4.4 (2.2; 633) 1.1 (0.89; 1,067) 3 (2.2; 725) 2.6 (1.5; 630)
After 2 (0.74; 3,064) 0.7 (1.3; 615) 1.1 (1.2; 710) 0.82 (0.9; 610)
COMFORT data consists of five behavioral COMFORT items; NIPS data consist of one compound score; PIPP data consist of three behavioral items, and
VAS data consist of one variable assessed either by a nurse or by the investigator on the basis of video observations. Data are mean (SD; no.).
NIPS, Neonatal Infant Pain Scale; PIPP, Premature Infant Pain Profile; VAS, Visual Analogue Scale.
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Figure 1 An overview of the modeling steps taken. The process starts by estimating the parameters for the graded response model to
come up with a latent variable, pain (Step 1). Then, the latent variable is regressed on the basis of suctioning status, drug concentra-
tion, and other covariates (Step 2), whereas also showing the results of Step 1 as a comparison. Finally, the findings from Step 2 are
transformed back to observational clinical scales (Step 3).
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time of pain observations, on the basis of individual
concentration-time data and postnatal age and body-
weight.11 Other tested covariates for pain include measures
for bodyweight, age, and study time.
Third, model-predicted changes in the latent variable
were statistically transformed back to the observational clin-
ical scales, detailed in subsection “Translation of the Latent
Variable to Observational Clinical Scales.”
Graded response model for pain
A graded response model was used to model ordered cate-
gorical data of the pain scores in an IRT framework, pre-
dicting the probabilities of observing a specific grade for
each of the items, as a function of pain. The pain measure-
ment data consisted of five investigator-assessed COM-
FORT items, three investigator-assessed PIPP items, the
nurse-assessed compound scores of NIPS, and VAS
scores assessed both by the investigators and nurses.
Similar to ordered categorical data, for measurement i at
suctioning state s (before, during, and after suctioning), for
item j , the probability of observation y being score k can
be calculated on the basis of the latent variable Dis (i.e.,
pain), a discrimination parameter aj and difficulty parame-
ters bjk
17 as outlined in Eq. 1. The item j refers to the sub-
scales of COMFORT or PIPP, or the total score of NIPS.
p yisj > k
 
5
eaj Dis2bjkð Þ
eaj Dis2bjkð Þ11
p yisj5k
 
5 p yisj > k21
 
2p yisj > k
 
(1)
Where difficulty parameters b are the latent variable thresh-
olds for 50% probability that the grade is higher than the
subscripted value, and discrimination parameters a
describe how well the item can separate different levels of
pain.
The scale of the latent variable Dis is a relative one,
therefore, its distribution needed to be defined. Within the
nonlinear mixed-effects modeling context this was done by
regarding this variable as a random effect18 with a fixed
standard normal distribution N(0,1). For the purposes of fit-
ting the graded response model, each measurement i was
interpreted as an independent observation, so that all the
observed variability in pain measurements is captured.
After fitting the graded response model, the model
parameters were fixed and continuous data of the VAS
scores was added. The relationship between the latent
variable and the continuous VAS data was described with
Eq. 2.
Predvas;is510  e
avas Dis2bvasð Þ
11eavas Dis2bvasð Þ
(2)
where the parameter avas is a steepness factor and the
parameter bvas is the threshold for the VAS score being 5.
Separate parameters were estimated for nurse-assessed
and investigator-assessed VAS scores. Additive and com-
bined additive and logit residual error models were tested
for the residual error of the VAS scores. A logit error model
alone was unfeasible because boundary values of VAS
scores were present. Once the parameters for VAS data
had been estimated, they were also fixed to their final
values.
To compare model predictions to observed data, summa-
ries of the model-predicted and empirical probabilities of
any given grade k occurring as a function of the latent vari-
able Di were compared. The empirical probabilities were
calculated by fitting an ordered categorical smoothing mod-
el for the grades as a function of the latent variable. The
mgcv package19 version 1.8-7 in R was used for this
purpose.
Pharmacodynamic modeling
After defining the scale of the latent variable and mapping
the parameters of the graded response model to this scale,
the parameter values of the graded response model were
fixed to allow the assessment of the influence of covariates
on changes in the latent variable within individuals. For this
PD modeling, measurements were treated as correlated
within individuals.
The pain (Dhis) for individual h at measurement i at state
s was described with Eq. 3.
Dhis5f s; hs; gs;h
 
2g Chi ; hdrug
 
1h covhi ; hcovð Þ (3)
where h are vectors of fixed effects and g are vectors of
random effects specific for individual h. The random effects
were assumed normally distributed with means of zero and
estimated SDs of xs. Covariances between the random
effects were estimated to account for intra-individual corre-
lations between the measurements at different states. The
modeling proceeded sequentially, and is described in detail
in the following paragraphs.
The first part of the above equation, Dhis5f s; hs; gs;h
 
, is
the model for baseline pain without drug effects or other
covariate effects. Different population estimates (hs) and
individual estimates (gs) of baseline pain were estimated
before, during, and after suctioning.
The second part of the above equation, g Chi ; hdrug
 
,
defines the effect of morphine, M3G, and M6G concentra-
tions on pain. Using a previously developed morphine PK
model for this population,11 individual PK parameter values
were obtained based on the individual morphine dosing
schedule (including both scheduled doses and rescue
doses), available concentration-time data for both morphine
and the morphine glucuronides, and postnatal age and
bodyweight of the patients. The individual PK parameters
were subsequently used to predict the drug concentrations
at the times of pain observations in the current study, which
is known as the individual PK parameter method of sequen-
tial PK-PD data analysis.20 Morphine and metabolite effects
on pain were tested with a linear relationship, power func-
tion, and maximum effect (Emax) models with and without
the Hill coefficient. The latter ones were tested only if the
linear relationship was statistically significant. Finally, differ-
ential morphine effects before, during, and after suctioning
were examined.
The third part of the overall model, h covhi ; hcovð Þ, defines
the remaining covariates for pain. Based on perceived
potential clinical relevance, the following covariates were
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tested with a linear relationship: average number of suction-
ing events per day, birth bodyweight, gestational age, post-
natal age, and study time, which was defined as the time
after the first dose or as the time after the first pain record-
ing in patients of the placebo group who did not receive
rescue morphine before the first pain recording. “Small for
gestational age” was tested as a categorical covariate.
Statistical testing was done based on Likelihood Ratio
Test with a P< 0.001 criterion for significance. Additionally,
we conducted an empirical assessment of significance lev-
els for our study according to W€ahlby et al.21 The details of
this procedure are described in Supplementary Electronic
Material S1 “Assessment of actual significance levels.” The
procedure was used to verify that the objective function is
truly v2 distributed.
Models were evaluated by assessing the precision of the
parameters in terms of SEs. Nonparametric bootstrap with
1,000 resampled datasets was used to obtain an alternative
set of confidence intervals for the model.22 Given the simi-
lar number of patients per treatment group, the bootstrap
was not stratified for this. Condition number, defined as the
largest eigenvalue of the covariance matrix divided by the
smallest eigenvalue of the covariance matrix, was used as
a general diagnostic of model overparameterization.
Translation of the latent variable to observational
clinical scores
To assess the clinical relevance of the covariate effects, the
expected values of the scores for item j , with scores k and
maximum score of K , were calculated as the sum of each
score k times the probability of that score occurring.
E yj
 
5
XK
k51
pjk  k
where pjk is the probability of k
th grade occurring for item j ,
calculated with the graded response model. With this in
mind, the expected values of each item were calculated as
a function of pain.
To calculate the expected value of total COMFORT-B
scores in the absence of the COMFORT item “muscle
tension,” the sum of the expected values of the included
COMFORT-B items was multiplied by 6/5, thus assuming
that the grade for muscle tension is equal to the average
score of the five other items. The same multiplication by 6/
5 was done for the observed COMFORT-B items. Because,
for the PIPP scale, only 3 of 7 items were included in the
model, no expected value of the total score for this scale
was calculated.
Changes in pain by drug concentrations and other covari-
ates were visualized for total COMFORT-B score and VAS,
because these are currently the most commonly used
scales in clinical practice.
RESULTS
Individual predicted morphine concentrations at the time
of pain assessment were mostly within the range of 0–
60 ng/mL (Figure 2a) and, thus, our modeling results
are restricted to that concentration range. We assessed
how close morphine concentrations during infusion were
to steady-state values at the times of the observational
clinical measurement. This was done by comparing the
predicted morphine concentration to the expected
steady-state concentration given the current infusion
rate. A histogram of concentrations in relation to the
steady state of the current individual is presented in
Figure 2b. This figure suggests the data may not be
supportive of estimating a distribution delay in PD
effects, because most of the concentrations are at or
near steady state. Most of the nonsteady-state observa-
tions were from individuals who had morphine concen-
trations of 0 (Figure 2c).
Figure 2 (a) A histogram of all morphine concentrations. (b) A histogram of the ratio between the predicted morphine concentration
and the predicted morphine steady state at the time of pain assessment. (c) A histogram of morphine concentrations when pain was
assessed but no infusion was ongoing (placebo group, for whom morphine rescue analgesia was allowed).
Morphine Pharmacodynamics in Preterm Neonates
V€alitalo et al.
243
www.psp-journal.com
Graded response model for pain
In the model for the latent variable pain, VAS scores were
described with an additive residual error model, as the
presence of VAS scores of 0 and 10 prevented the use of a
logit-error model.
Figure 3 shows the model predictions of the probability
for a given grade to occur (solid, colored lines), and the
empirical probability densities of the grades (colored areas).
Based on the agreement between the model predictions
and the empirical probabilities, it can be concluded that the
graded response model is able to describe pain as a latent
variable.
The parameters relating to the graded response model
and the model for VAS scores as a function of the latent
variable are provided as Supplementary Electronic Mate-
rial S2. A moderate variability was found in the discrimina-
tion parameters a, suggesting that the informativeness of
the items is not equal.
Pharmacodynamic model
Morphine was found to decrease pain in a concentration-
dependent manner, and increasing study time was associ-
ated with increased pain. The final model is described with
the equation below and the final model parameter esti-
mates are presented in Table 2. The SEs of the
parameters were low, and the condition number of 47.89
was well below the critical value of 1,000, demonstrating
that the model is supported well by the data.23
Dshi5f s; hs; gs;h
 
2Chi ;morph  hmorph1thi  htime
where the first part of the equation means that both the
median and individual baseline pain state are different
depending on the suctioning status s.
The typical latent variable during suctioning was about
one unit higher than the typical latent variable values before
or after suctioning (Table 2). The correlation between ran-
dom effects before and during suctioning was 54%, correla-
tion during and after suctioning was 44%, and correlation
before and after suctioning was 69%.
A linear model best described the relationship between
morphine concentration and pain (P < 0:001,
dOFV5272:91). More complex concentration-effect rela-
tionships did not improve the model statistically significantly,
nor were the morphine glucuronide concentrations found to
have an effect on pain after the inclusion of morphine as a
predictor. No delay, by means of an effect compartment
model, could be estimated between morphine plasma con-
centration and effect. A model differentiating between mor-
phine effects before, during, and after suctioning confirmed
Figure 3 Item-grade probability curves. X-axis is the latent variable and Y-axis represents the probability of each grade occurring. Each
color represents a specific grade, between 0 and 7. Solid lines are predictions from the graded response model and dashed lines with
shaded areas are a smoothed mean and 95% confidence interval for the raw data. For COMFORT (abbreviated as CMT), colors repre-
senting grades from 1–5 are present, for Neonatal Infant Pain Scale (NIPS) color representing grades from 0–7 are present, and for
preterm infant pain profile (PIPP) colors representing grades from 0–3 are present, according to the discrimination and difficulty values
of the grades of these items.
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that the morphine effect is consistent across the three
states, as the efficacy estimates hmorph of morphine were
largely similar regardless of suctioning status. A model with
differential morphine effects did not result in significant
improvement. Adding a random effect on morphine efficacy
resulted in unacceptably high relative SE (71%) on the pop-
ulation estimate of morphine efficacy. As a sensitivity analy-
sis, the pain data subsequent to rescue analgesia were
excluded and the final model was rerun. In this case, the
morphine effect became highly uncertain with a relative SE
of 132%.
Of the other covariates, study time and postnatal age
were associated with increased pain (P < 0:001,
dOFV52105:54). However, the two covariates are collinear
because an overwhelming majority (n5 133; 95%) of the
neonates entered the study within a postnatal age of one
day. Of the two, study time was selected as the clinically
most likely causal covariate and included in the model. The
number of suctionings per day in each patient was not cor-
related to the baseline pain (hs) of patients.
The effect of fixing IRT parameters values for the
PD model is discussed in Supplementary Electronic
Material S3, and the identifiability of the model without fix-
ing these parameters is discussed in Supplementary Elec-
tronic Material S4. The PD model would be unidentifiable
if the IRT model parameters were estimated together with
the mean and variance of the latent variable.
Translation of the latent variable to observational
clinical scales
The observed vs. predicted VAS and COMFORT-B scores
before, during, and after suctioning are shown in Figure 4.
A moderate level of agreement can be seen in individual
predictions vs. observations, and a mild agreement
between population predictions and observations.
Supplementary Figure S1 presents the expected values
of individual pain grades as a function of the latent variable.
Figure 5 summarizes the expected values of COMFORT-B
and VAS during suctioning as a function of morphine con-
centration and study time. As morphine concentrations
increase from 0 to 20 ng/mL, the COMFORT-B score is
expected to drop by one unit, and VAS score by <0.5 units,
on average. As study day increases from 0 to 7, the
COMFORT-B score is expected to increase by about two
units, and VAS score by approximately one unit, on aver-
age. Although Figure 5 shows the effects of morphine and
study time only during suctioning, the drug effects are simi-
lar before and after suctioning.
DISCUSSION
In this study, we have quantified the concentration-effect
relationship of morphine in mechanically ventilated preterm
neonates undergoing endotracheal suctioning. To our
knowledge, this is the first analysis using item-level pain
measurement data in a latent variable model to estimate
analgesic morphine effects. In contrast to the statistical
analysis of the original study,1 we have detected an analge-
sic effect, although clinically insignificant, of morphine using
advanced modeling techniques. Morphine PDs are notori-
ously hard to quantify, with large interindividual variability in
morphine efficacy24,25 and large variability in pain readings
between individuals and between assessments, as
observed in the current study.
We argue that the ability to detect a morphine effect in
the current study results from the increased statistical pow-
er obtained by using advanced data analysis methods; non-
linear mixed-effects modeling together with IRT. The
original analysis featured a statistical between-group com-
parison of NIPS, PIPP, and VAS scores in a morphine arm
vs. placebo arm, whereas both treatment arms were
allowed open-label morphine as rescue analgesia. The
study was intended as a pragmatic trial to inform about
choices between treatments,1 and the original analysis was
certainly best suited for that purpose. However, for the pur-
poses of quantifying drug effects, concentration-effect
modeling is more powerful as it relates drug concentrations
to effects instead of relating treatment arm to group effects.
Moreover, individuals who experience more pain are also
more likely to receive rescue analgesia; therefore, a
population-level comparison of drug concentrations vs. pain
levels could appear to indicate that morphine causes pain.
Using nonlinear mixed-effects modeling to separate interin-
dividual variability in baseline pain from the intra-individual
drug effects, we observe a small intra-individual drug effect
(Figure 5). Furthermore, this drug effect cannot be quantified
if pain data subsequent to rescue analgesia are omitted,
which results in patients either having drug concentrations of
zero (placebo arm) or steady-state morphine concentrations
(treatment arm).
Table 2 Parameter estimates from final model and bootstrap (n5 1,000)
Parameter Symbol Value (SE) Bootstrap CI (5–95%)
Baseline pain, before suction hbl ;1 20.27 (0.0615) 20.387 to 20.177
xbl ;1 0.558 (0.0271) 0.483 to 0.636
Baseline pain, during suction hbl ;2 1.15 (0.0581) 1.04 to 1.24
xbl ;2 0.583 (0.0237) 0.514 to 0.65
Baseline pain, after suction hbl ;3 20.393 (0.0602) 20.502 to 20.297
xbl ;3 0.563 (0.0231) 0.494 to 0.634
Morphine effect slope (ng/mL)21 hmorph 0.0091 (0.0016) 0.00567 to 0.0116
Study time slope (1/day) htime 0.0476 (0.0185) 0.018 to 0.0782
The symbol h denotes a fixed effect for a typical population estimate and the symbol x denotes the magnitude of between-subject variability, expressed as a SD.
CI, confidence interval.
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Figure 5 Expected values of COMFORT-B and visual analogue scale (VAS), vs. (a) morphine concentration and (b) time after study
start. Solid black line is the population median value of pain, the dark shaded area is the 25–75% most commonly occurring pain range
and light shaded area is the 2.5–97.5% most commonly occurring pain range, calculated based on the between-subject variability of
pain during endotracheal suctioning.
Figure 4 Observed vs. predicted plot for COMFORT-B (a) and visual analogue scale (VAS) (b) with population predictions in the upper
rows and individual predictions in the lower rows. The gray dashed line is the line of unity and solid blue line is local regression
smoothing. Because the pain levels were almost identical before and after suctioning, these two states were combined within this plot.
To correct for the missing item “muscle tension,” the observed and predicted sums of the existing items were multiplied by 6/5 to arrive
at the total COMFORT-B score.
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A further increase in statistical power is gained by the
use of IRT modeling, or latent variable modeling in general.
We recently showed that the informativeness of the PIPP
and COMFORT individual items is highly variable.9 There-
fore, if the items are summed together, some of the items
may add more noise than information to the analysis. On
the other hand, if the data are analyzed with a latent vari-
able model, each item affects the objective function differ-
ently, which can be interpreted as the item being “weighted”
by its informativeness. Differences in the discrimination
parameters a between the included items (Supplementary
Electronic Material S2), suggest that the items within the
dataset have differing sensitivity to pain and their contribu-
tion to the model fit are scaled accordingly. Latent variable
modeling also enables the use of observation sets with one
or more items missing, thus enabling more comprehensive
use of the available data.
Morphine target concentrations of around 20 ng/mL have
been reported26,27 for postoperative pain in neonates, con-
centration well above this value have been observed in the
current analysis. On average, morphine concentration
increasing from 0–20 ng/mL decreases total COMFORT-B
scores by approximately one grade, and VAS scores by
approximately one-half a grade (Figure 5a). Considering
that the average COMFORT-B grade is 18 during suctioning
and 12 before/after suctioning (Table 1), the applied
morphine-dosing algorithm does not yield concentrations
that provide clinically relevant analgesia that would justify
its use for suctioning-related acute pain. Given the linear
relationship between morphine concentration and effect,
extrapolations of our findings to higher concentrations are
not possible, moreover, higher concentrations would likely
yield an increase in undesirable side effects. It should also
be noted that the current results of morphine efficacy can-
not be generalized to other, potentially more severe types
of pain experienced by children, such as postoperative pain
or pain caused by necrotizing enterocolitis.
The pain scales used in our analysis are validated, widely
accepted, and show good inter-rater reliability.7,8,12,28–30
However, it should be acknowledged that the items included
in this analysis are measuring the signals of pain and dis-
tress from the neonate, not the absolute pain itself.31 The
observed signals can be affected (i) by the pain experienced
by the neonate, (ii) by the distress experienced by the neo-
nate, and (iii) by the ability of the neonate to express pain
and distress. As such, it is possible that the modest associa-
tion between study time and pain (Figure 5b) results from
antenatal maturation of the neonates, and them becoming
more able to express pain. However, it is also possible that
the suctioning procedure gradually becomes more painful
as it is repeated many times per day over the duration of
the study.
In conclusion, we have built a model to describe and pre-
dict pain in mechanically ventilated preterm neonates under-
going endotracheal suctioning, based on several validated
pain measures for this patient population. Using these, we
have constructed a latent variable to represent pain, and per-
formed a PD analysis on the latent variable. IRT enabled us
to quantify a mild analgesic effect of morphine in mechanical-
ly ventilated preterm neonates, however, this analgesic effect
is not enough to advocate routine morphine use in these
patients.
Additional Supporting Information may be found in the online
version of this article.
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